Gambia vs Madagascar: Cause of death, by non-communicable diseases, female
Gambia
42.5%
in 2021
Madagascar
42.5%
in 2021
Gambia rank
153rd
Madagascar rank
154th
Cause of death, by non-communicable diseases, female over time
- Gambia
- Madagascar
How they compare
Gambia currently reports 42.5% against 42.5% in Madagascar, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Madagascar ahead.
Gambia ranks 153rd and Madagascar ranks 154th of 185 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Madagascar in 2.
Head to head by decade
| Decade | Gambia | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.5% | 31.8% | 3.3% | Madagascar |
| 2010s | 38.6% | 42.6% | 3.9% | Madagascar |
| 2020s | 43.0% | 43.0% | 0.0% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Gambia or Madagascar?
- Gambia, at 42.5% against 42.5% in Madagascar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Gambia and Madagascar?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Madagascar?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Madagascar rank globally for cause of death, by non-communicable diseases, female?
- Gambia ranks 153rd and Madagascar ranks 154th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.